Cargando…

Can ACE-I Be a Silent Killer While Normal Renal Functions Falsely Secure Us?

The current case report represents a warning against serious hyperkalaemia and acidosis induced by ACE-I during surgical stress while normal renal function could deceive the attending anaesthetist. Arterial gas analysis for follow-up of haemoglobin loss accidentally discovered hyperkalaemia and acid...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdelaal Ahmed Mahmoud, Ahmed, Campbell, Mark, Blajeva, Margarita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6077600/
https://www.ncbi.nlm.nih.gov/pubmed/30112218
http://dx.doi.org/10.1155/2018/1852016
_version_ 1783344950454255616
author Abdelaal Ahmed Mahmoud, Ahmed
Campbell, Mark
Blajeva, Margarita
author_facet Abdelaal Ahmed Mahmoud, Ahmed
Campbell, Mark
Blajeva, Margarita
author_sort Abdelaal Ahmed Mahmoud, Ahmed
collection PubMed
description The current case report represents a warning against serious hyperkalaemia and acidosis induced by ACE-I during surgical stress while normal renal function could deceive the attending anaesthetist. Arterial gas analysis for follow-up of haemoglobin loss accidentally discovered hyperkalaemia and acidosis. Glucose-insulin and furosemide successfully corrected hyperkalaemia after 25 minutes and acidosis after 3 hours. These complications could be explained by a deficient steroid stress response to surgery secondary to suppression by ACE-I. Event analysis and database search found that ACE-I induced aldosterone deficiency aggravated by surgical stress response with an inadequate increase in aldosterone secretion due to angiotensin II deficiency as a sequel of ACE-I leading to defective secretion of H+ and K+. Furosemide is recommended to secrete H+ and K+ compensating for aldosterone deficiency in addition to other antihyperkalaemia measures. Anaesthetising an ACE-I treated patient requires considering ACE-I as a potential cause of hyperkalaemia and acidosis.
format Online
Article
Text
id pubmed-6077600
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-60776002018-08-15 Can ACE-I Be a Silent Killer While Normal Renal Functions Falsely Secure Us? Abdelaal Ahmed Mahmoud, Ahmed Campbell, Mark Blajeva, Margarita Case Rep Anesthesiol Case Report The current case report represents a warning against serious hyperkalaemia and acidosis induced by ACE-I during surgical stress while normal renal function could deceive the attending anaesthetist. Arterial gas analysis for follow-up of haemoglobin loss accidentally discovered hyperkalaemia and acidosis. Glucose-insulin and furosemide successfully corrected hyperkalaemia after 25 minutes and acidosis after 3 hours. These complications could be explained by a deficient steroid stress response to surgery secondary to suppression by ACE-I. Event analysis and database search found that ACE-I induced aldosterone deficiency aggravated by surgical stress response with an inadequate increase in aldosterone secretion due to angiotensin II deficiency as a sequel of ACE-I leading to defective secretion of H+ and K+. Furosemide is recommended to secrete H+ and K+ compensating for aldosterone deficiency in addition to other antihyperkalaemia measures. Anaesthetising an ACE-I treated patient requires considering ACE-I as a potential cause of hyperkalaemia and acidosis. Hindawi 2018-07-09 /pmc/articles/PMC6077600/ /pubmed/30112218 http://dx.doi.org/10.1155/2018/1852016 Text en Copyright © 2018 Ahmed Abdelaal Ahmed Mahmoud et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Abdelaal Ahmed Mahmoud, Ahmed
Campbell, Mark
Blajeva, Margarita
Can ACE-I Be a Silent Killer While Normal Renal Functions Falsely Secure Us?
title Can ACE-I Be a Silent Killer While Normal Renal Functions Falsely Secure Us?
title_full Can ACE-I Be a Silent Killer While Normal Renal Functions Falsely Secure Us?
title_fullStr Can ACE-I Be a Silent Killer While Normal Renal Functions Falsely Secure Us?
title_full_unstemmed Can ACE-I Be a Silent Killer While Normal Renal Functions Falsely Secure Us?
title_short Can ACE-I Be a Silent Killer While Normal Renal Functions Falsely Secure Us?
title_sort can ace-i be a silent killer while normal renal functions falsely secure us?
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6077600/
https://www.ncbi.nlm.nih.gov/pubmed/30112218
http://dx.doi.org/10.1155/2018/1852016
work_keys_str_mv AT abdelaalahmedmahmoudahmed canaceibeasilentkillerwhilenormalrenalfunctionsfalselysecureus
AT campbellmark canaceibeasilentkillerwhilenormalrenalfunctionsfalselysecureus
AT blajevamargarita canaceibeasilentkillerwhilenormalrenalfunctionsfalselysecureus